These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 10564952

  • 1. High rate of small TP53 mutations and infrequent loss of heterozygosity in malignant liver tumors associated with thorotrast: implications for alpha-particle carcinogenesis.
    Wada I, Horiuchi H, Mori M, Ishikawa Y, Fukumoto M, Mori T, Kato Y, Kitagawa T, Machinami R.
    Radiat Res; 1999 Dec; 152(6 Suppl):S125-7. PubMed ID: 10564952
    [Abstract] [Full Text] [Related]

  • 2. Alpha-particle carcinogenesis in Thorotrast patients: epidemiology, dosimetry, pathology, and molecular analysis.
    Ishikawa Y, Wada I, Fukumoto M.
    J Environ Pathol Toxicol Oncol; 2001 Dec; 20(4):311-5. PubMed ID: 11797840
    [Abstract] [Full Text] [Related]

  • 3. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles.
    Andersson M, Jönsson M, Nielsen LL, Vyberg M, Visfeldt J, Storm HH, Wallin H.
    Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(7):765-70. PubMed ID: 8672994
    [Abstract] [Full Text] [Related]

  • 4. Analysis of genetic changes in intrahepatic cholangiocarcinoma induced by thorotrast.
    Kamikawa T, Amenomori M, Itoh T, Momoi H, Hiai H, Machinami R, Ishikawa Y, Mori T, Shimahara Y, Yamaoka Y, Fukumoto M.
    Radiat Res; 1999 Dec; 152(6 Suppl):S118-24. PubMed ID: 10564951
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Genetic aberration in primary hepatocellular carcinoma: correlation between p53 gene mutation and loss-of-heterozygosity on chromosome 16q21-q23 and 9p21-p23.
    Wang G, Huang CH, Zhao Y, Cai L, Wang Y, Xiu SJ, Jiang ZW, Yang S, Zhao T, Huang W, Gu JR.
    Cell Res; 2000 Dec; 10(4):311-23. PubMed ID: 11191353
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clonal origin of multifocal hepatocellular carcinoma.
    Hodges KB, Cummings OW, Saxena R, Wang M, Zhang S, Lopez-Beltran A, Montironi R, Nour H, Cheng L.
    Cancer; 2010 Sep 01; 116(17):4078-85. PubMed ID: 20564142
    [Abstract] [Full Text] [Related]

  • 16. Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan.
    Wada I, Kanada H, Nomura K, Kato Y, Machinami R, Kitagawa T.
    Hepatology; 1999 Jun 01; 29(6):1718-21. PubMed ID: 10347113
    [Abstract] [Full Text] [Related]

  • 17. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
    Cazals-Hatem D, Rebouissou S, Bioulac-Sage P, Bluteau O, Blanché H, Franco D, Monges G, Belghiti J, Sa Cunha A, Laurent-Puig P, Degott C, Zucman-Rossi J.
    J Hepatol; 2004 Aug 01; 41(2):292-8. PubMed ID: 15288479
    [Abstract] [Full Text] [Related]

  • 18. Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas.
    Plisiecka-Hałasa J, Dansonka-Mieszkowska A, Kraszewska E, Dańska-Bidzińska A, Kupryjańczyk J.
    Anticancer Res; 2008 Aug 01; 28(2A):989-96. PubMed ID: 18507046
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.